Financial statements Viva Apteka
Balance sheet data of VIVA APTEKA
|
Year
|
2018
|
2019
|
2020
|
2021
|
2022
|
2023
|
|---|---|---|---|---|---|---|
| Total assets | 2 783 476,31 | 1 795 794,75 | 1 734 595,95 | 1 777 878,76 | 1 882 813,60 | 1 843 603,70 |
| A. Fixed assets | 1 485 461,42 | 1 406 436,48 | 1 361 691,95 | 1 317 630,79 | 1 391 354,99 | 1 335 166,19 |
| B. Current assets | 1 298 014,89 | 389 358,27 | 372 904,00 | 460 247,97 | 491 458,61 | 508 437,51 |
| C. Share capital contributions (basic funds) | - | - | - | - | - | - |
| D. Own shares (stocks) | - | - | - | - | - | - |
| Total liabilities | 2 783 476,31 | 1 795 794,75 | 1 734 595,95 | 1 777 878,76 | 1 882 813,60 | 1 843 603,70 |
| A. Equity | 789 999,90 | 350 627,83 | 583 327,36 | 667 500,59 | 759 103,17 | 837 912,29 |
| B. Liabilities and provisions for liabilities | 1 993 476,41 | 1 445 166,92 | 1 151 268,59 | 1 110 378,17 | 1 123 710,43 | 1 005 691,41 |
| I. Long-term liabilities | 389 164,00 | 320 488,00 | 251 812,00 | 183 136,00 | 114 460,00 | 45 784,00 |
| II. Short-term liabilities | 910 316,76 | 452 370,63 | 248 835,66 | 298 308,60 | 402 004,22 | 374 348,56 |
Financial data is automatically retrieved from the EKRS webpage of the Ministry of Justice.
- Fixed Assets - Assets held for a longer period, typically longer than a year, such as real estate or machinery.
- Current Assets - Assets intended to be used or sold within a year, such as inventory, receivables, and cash.
- Equity - The net value of a company's assets, representing the difference between its assets and liabilities.
- Long-Term Liabilities - Financial obligations to be repaid over a period longer than a year, such as loans or bonds.
- Short-Term Liabilities - Financial obligations to be repaid within a year, such as payables to suppliers or short-term loans.
- Reserve Capital - A portion of equity set aside for specific purposes, such as covering losses or business development.